Massive opportunity.
This blip affects a drop in their customer bucket. Scott Phillips of Motley Fool waxing lyrical on Sky Business tonight, he has a screaming buy on it.
Arguments in favour;
1) US population fighting obesity in significant numbers
2) An ageing Australian and Chinese population
3) No competition for RMD product range (SOM and Co have very different products).
It affects 2% of their current revenue/customer base, the market share going forward is expanding exponentially.
Where does this end?, page-39
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$28.60 |
Change
-0.500(1.72%) |
Mkt cap ! $18.16B | |||
| Open | High | Low | Value | Volume |
| $28.50 | $28.87 | $28.33 | $85.93M | 2.994M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1039 | $28.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $28.60 | 42301 | 5 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| RMD (ASX) Chart |